Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol
Christopher Kudrich, Yasmin L. Hurd, Edwin A. Salsitz, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 5, pp. 569-581
Open Access | Times Cited: 10

Showing 10 citing articles:

THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 52
Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review
Lindsay A. Lo, Caroline A. MacCallum, Kate Nanson, et al.
The Canadian Journal of Psychiatry (2023) Vol. 68, Iss. 8, pp. 557-571
Open Access | Times Cited: 8
Cannabinoids for Substance Use Disorder Treatment: What Does the Current Evidence Say?
João Ariel Bonar Fernandes, Renato Filev, Thiago Marques Fidalgo
Cannabis and Cannabinoid Research (2023) Vol. 8, Iss. 5, pp. 703-715
Closed Access | Times Cited: 5
Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder
Christopher Kudrich, Rebecca Chen, Meng Yuan, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
The Therapeutic Potential of Cannabidiol in Revolutionising Opioid Use Disorder Management
Kelvin Le, Joanne Au, Jean Hua, et al.
Cureus (2023)
Open Access | Times Cited: 2
Effects of CB1 receptor negative allosteric modulator Org27569 on oxycodone withdrawal symptoms in mice
Rhianne L. Scicluna, Nicholas A. Everett, Connie J. Badolato, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1705-1717
Open Access
The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder
Kelvin Le, Khang Duy Ricky Le, Johnny Nguyen, et al.
Pain and Therapy (2024) Vol. 13, Iss. 3, pp. 435-455
Open Access
Cannabidiol, a promising therapy for post-traumatic stress disorder and depression. A mini-review
George Jîtcă
Acta Marisiensis. Seria Medica (2024) Vol. 70, Iss. 2, pp. 37-41
Open Access
Long-term treatment for unspecified anxiety disorders with cannabidiol (CBD): A retrospective case series from real-world evidence (RWE) in Colombia
Juan F. Gálvez‐Flórez, Hernan Felipe Guillén-Burgos, Camilo A Flórez-Puentes, et al.
Medical Cannabis and Cannabinoids (2024) Vol. 7, Iss. 1, pp. 193-205
Open Access
The Use of Cannabis for Pain Management
Rahim Valani
Springer eBooks (2022), pp. 107-117
Closed Access
Page 1

Scroll to top